ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,349Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 68

$595K Total Retail Price of All Prescriptions

Rank: 12 out of 68

209 Patients Receiving at Least One Drug in Part D
99%Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

21% of this provider’s 209 patients filled at least one prescription for a schedule two drug, compared to an average of 11%.

Schedule Three
Controlled Substances

8% of this provider’s 209 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

0% of this provider’s 12,339 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

59 is the average number of prescriptions (including refills) per patient, compared to an average of 29.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
WARFARIN SODIUM 820 820 1 8
LEVOTHYROXINE SODIUM 731 731 2 2
OMEPRAZOLE 699 699 3 5
FUROSEMIDE 585 585 4 3
METOPROLOL TARTRATE 465 465 5 6
POLYETHYLENE GLYCOL 3350 323 323 6 22
LISINOPRIL 317 314 7 4
AMLODIPINE BESYLATE 274 274 8 7
SIMVASTATIN 257 257 9 1
POTASSIUM CHLORIDE 250 250 10 18
PANTOPRAZOLE SODIUM 233 233 11 30
GABAPENTIN 221 221 12 12
SERTRALINE HCL 208 208 13 20
ATENOLOL 171 171 14 21
IPRATROPIUM BROMIDE 169 169 15 150
ESCITALOPRAM OXALATE 157 157 16 38
CITALOPRAM HBR 146 145 17 9
GLIPIZIDE 145 145 18 54
DONEPEZIL HCL 145 145 18 10
CYMBALTA 145 145 18 59
MIRTAZAPINE 144 143 21 15
ALBUTEROL SULFATE 135 135 22 77
DIGOXIN 129 129 23 45
TAMSULOSIN HCL 124 124 24 28
HYDROCHLOROTHIAZIDE 121 121 25 11
CLOPIDOGREL 119 119 26 31
ATORVASTATIN CALCIUM 119 119 26 13
NAMENDA 116 116 28 16
LANTUS 97 97 29 36
METOPROLOL SUCCINATE 96 96 30 19
QUETIAPINE FUMARATE 96 96 30 33
HYDROCORTISONE 96 96 30 108
METFORMIN HCL 95 95 33 14
ISOSORBIDE MONONITRATE ER 94 94 34 35
LIDODERM 89 89 35 68
ALENDRONATE SODIUM 86 86 36 26
ABILIFY 83 83 37 121
NYSTOP 83 83 37 106
PREDNISONE 81 81 39 47
GLIMEPIRIDE 81 81 39 69
IPRATROPIUM-ALBUTEROL 79 79 41 52
VENLAFAXINE HCL ER 77 77 42 84
LEVOFLOXACIN 74 74 43 91
DILTIAZEM 24HR CD 70 70 44 86
KLOR-CON M20 69 69 45 40
PRAVASTATIN SODIUM 65 65 46 29
TRAMADOL HCL 59 59 47 23
CARVEDILOL 59 59 47 27
HYDROCODONE-ACETAMINOPHEN 59 59 S3 47 17
CARBIDOPA-LEVODOPA 58 58 50 50
NYSTATIN 56 56 51 74
CALCITONIN-SALMON 54 54 52 185
TAMIFLU 53 53 53 165
LATANOPROST 52 52 54 63
PLAVIX 50 50 55 48
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.